LexDanaLexDanabeta
Inventor

Leda Mannent

Inventor
Paris, FR

Overview

3→
Patents
2018–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07KPeptides30%
A61BDiagnosis10%
PatentTitleYear
11,053,309Methods for treating active eosinophilic esophagitis202110,066,017Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist201810,059,771Methods for treating nasal polyposis by administering an IL-4R antagonist2018

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2018–2021Patents assigned to REGENERON PHARMA (3)· patent assignee history
2018–2021Patents assigned to SANOFI BIOTECHNOLOGY (3)· patent assignee history
2018–2021Based in Paris, FR· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
REGENERON PHARMA32018–2021
SANOFI BIOTECHNOLOGY32018–2021
Locations
LocationPatentsSpan
Paris, FR32018–2021